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Pericardial infection caused by
Brevibacterium casei
In response to the article describing two cases of
catheter-related bacteraemia associated with Brev-
ibacterium casei in the May 2004 issue of Clinical
Microbiology and Infection [1], we wish to report an
unusual case of B. casei infection that was encoun-
tered recently at our institution.
A 78-year-old man with a history of cancer was
admitted with fatigue, shortness of breath, loss of
appetite, and intermittent chest pain. The patient
was afebrile, but hypotensive (blood pressure,
68 ⁄ 39 mmHg), tachycardiac (heart rate, 124 ⁄min),
tachypenic (respiratory rate, 28 ⁄min) and hypoxic
(oxygenation saturation, 88% on room air). On
examination, there was an irregular heart rhythm,
but without murmurs or gallop or peripheral
signs of endocarditis. Initial laboratory values
included a white blood cell count of 11 100 ⁄mm3
(84% segmented neutrophils, 6% lymphocytes,
8% monocytes, 1% eosinophils and 1% basoph-
ils), haemoglobin 8.3 g ⁄dL, and platelets
202 000 ⁄mm3. Blood and urine cultures were
negative. A trans-thoracic echocardiogram re-
vealed a moderate-to-large pericardial effusion
with right ventricle collapse. An emergent peri-
cardiocentesis drained 570 mL of thick, bloody
fluid. Pericardial fluid analysis revealed 140 000
red blood cells ⁄mm3, 208 white blood cells ⁄mm3
(73% neutrophils, 27% lymphocytes), protein
4.8 g ⁄dL, glucose 160 mg ⁄dL, amylase 13 U ⁄L
and lactic dehydrogenase 4219 U ⁄dL. Cytopatho-
logical analysis of the pericardial fluid showed
acute and chronic inflammatory cells with react-
ive mesothelial cells. Culture of the pericardial
fluid was positive for B. casei, and treatment with
intravenous vancomycin was started.
Antimicrobial sensitivity testing was per-
formed in conventional Gram-positive MicroScan
(Sacramento, CA, USA) panels via broth micro-
dilution, and was interpreted according to the
breakpoints recommended by Funke et al. [2].
The organism was sensitive to ceftriaxone
(MIC £ 4 mg ⁄L), ciprofloxacin (MIC £ 1 mg ⁄L),
erythromycin (MIC £ 0.5 mg ⁄L), rifampicin
(MIC £ 1 mg ⁄L), tetracycline (MIC £ 4 mg ⁄L)
and vancomycin (MIC £ 2 mg ⁄L), but was resist-
ant to ampicillin (MIC 4 mg ⁄L), amoxycillin–
clavulanic acid (MIC > 4 ⁄ 2 mg ⁄L), clindamycin
(MIC > 2 mg ⁄L) and penicillin (MIC 2 mg ⁄L).
The patient’s condition improved initially, but a
gastrointestinal bleed and atrial fibrillation, with
rapid ventricular response, developed after a
further 11 days, and the patient subsequently
died.
The genus Brevibacterium was first described in
the 1950s [3], but Brevibacterium spp. have been
implicated only rarely as human pathogens
[1,3–15]. Brevibacterium spp. are Gram-positive
coryneform bacilli that are found frequently in
dairy products. Some species (e.g., B. casei and
Brevibacterium epidermidis) may be part of the
normal human skin flora [3,16]. To date, Brevi-
bacterium spp. have been identified in clinical
specimens, but B. casei appears to be the most
common [17]. Fourteen case reports of Brevi-
bacterium spp. infections can be found in the
literature [1,4–15]. Manifestations have included
bacteraemia, with or without associated central
venous catheter infection (n = 10), peritonitis
(n = 2), endocarditis (n = 1) and sternal osteomy-
elitis (n = 1). Most clinical Brevibacterium isolates
have been reported to be susceptible to b-lactams,
ciprofloxacin and vancomycin. To our know-
ledge, the present case is the first report of
pericardial infection caused by Brevibacterium
spp. These organisms appear to be opportunistic
pathogens, with most reported cases involving
patients with an underlying malignancy or
immunodeficiency disease. The possibility of
Brevibacterium infection should be considered in
the context of pericarditis among immunocom-
promised patients.
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